Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cardiovascular Manifestations in Post-COVID-19 Patients
Author(s): Angela Cozma , Violeta Briciu , Adela Viviana Sitar-Tăut , et al Added: 1 month ago

Heart Failure

Prevention & Chronic Conditions
AHA 24: The EMPEROR-Preserved Trial
Author(s): Andrew JS Coats Added: 5 months ago
AHA Conference 2024 - Discover the findings from a new study on the impact of diastolic dysfunction on the efficacy of empagliflozin in heart failure in the EMPEROR-Preserved trial.Prof Andrew Coats (Heart Research Institute, New South Wales, AU) joins us onsite at AHA Conference to discuss findings from a new analysis of diastolic dysfunction in the EMPEROR-Preserved trial (NCT03057951).EMPEROR… View more

Heart Failure
The WICD-MI Study
Author(s): Mathieu Echivard Added: 4 days ago
ESC HFA 25 - The WICD-MI study finds heart failure to be frequent in patients with persistent left ventricular dysfunction after acute myocardial infarction.We are joined onsite by Dr Mathieu Echivard (University Hospital of Nancy, Nancy, FR) to discuss key findings from a study investigating heart failure events in patients with persistent left ventricular dysfunction after acute myocardial… View more

Heart Failure

MI/ACS
Obesity, Cardiac MRI Structure and Non-ischaemic Cardiomyopathy
Author(s): Long Peng , Tao Zeng , Enxi Quan , et al Added: 1 week ago

Cardiovascular Renal Metabolic

Heart Failure
ESC HF 25: The Heart2Miss Study
Author(s): Diana Hui Ping Foo Added: 4 days ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,… View more

Heart Failure

Imaging & Diagnostics
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF
Author(s): Domingo Figal Added: 2 years ago
ESC-HFA 2023 — Prof Domingo Pascual Figal (Hospital Clinico Universitario Virgen de la Arrixaca, SP) discusses the DAPA MODA study (NCT04707352). The study aimed to assess the effects of dapagliflozin on cardiac remodeling parameters, particularly LA geometry and function, and biomarkers reflecting pathophysiological pathways. Findings from ESC Heart Failure 2023 revealed that dapagliflozin… View more

Heart Failure
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis
Author(s): Marianna Fontana Added: 2 years ago
ESC-HFA 23 — We are joined by Prof Marianna Fontana (University College London, UK), as she outlines the key findings from the phase 3 APOLLO-B study (Alnylam Pharmaceuticals) (NCT03997383). APOLLO-B investigated the use of patisiran, a transthyretin-directed small interfering RNA, in a cohort of patients with cardiac amyloidosis. 360 patients were enrolled in the trial and were randomized 1:1… View more

Heart Failure
RDW Prognostic Marker in HF and Predictor for Iron Replacement Responsivene
Author(s): Artemio García-Escobar , Rosa Lázaro-García , Javier Goicolea-Ruigómez , et al Added: 5 months ago

Heart Failure
Comparison of Haemodynamic Responses to Landiolol Versus Esmolol
Author(s): Georgios Koukoulitsios , Kyriaki Tsikritsaki , Georgios Magklaras , et al Added: 1 day ago

Heart Failure

Vascular Disease and Surgery
Effects of GLP-1 Receptor Agonists in Heart Failure Patients
Author(s): Anastasia Shchendrygina , Amina Rakisheva , Ilya Giverts , et al Added: 8 months ago

Heart Failure